MUNDELEIN, Ill., March 3 /PRNewswire/ -- Sysmex America, Inc., a world leader in laboratory design, systemization and solutions, announced today that Consorta, Inc., a leading healthcare resource management and group purchasing organization, has extended its hematology contract with Sysmex America for reagents, instruments and service until 2007. Under the terms of this agreement, Sysmex will sell and service the Sysmex analyzers and reagents to Consorta members. Training and technical support for the analyzers will be provided through Sysmex’s Mundelein office.
“Sysmex America provides a strong product offering in the field of hematology,” said John Kershaw, Chief Operating Officer, Sysmex America. “We believe that the extension of our hematology contract with Consorta is indicative of the performance, reliability and responsiveness that laboratory managers across the country have learned to expect from Sysmex hematology products,” said Kershaw.
Under the contract, Sysmex offers Consorta members a comprehensive portfolio of Sysmex hematology products ranging from the pocH-100i(TM) and the KX-21N(TM) for small laboratories to the fully automated XE-Alpha N(TM) and HST-N(TM) Integrated Hematology Systems with automated slide preparation capabilities. Also included are the Sysmex XE-2100(TM), XE-2100L(TM) and XE- 2100D(TM) Automated Hematology Analyzers and the Sysmex XT-2000i(TM) and XT- 1800i(TM) Automated Hematology Analyzers, all of which use the same fluorescent flow technology platform, user interface, and reagents and controls, leading to improved laboratory standardization. The CellaVision(TM) Digital Cell Morphology System is another new addition to the contract.
Sysmex hematology analyzers have been ranked the best in the industry for performance and reliability for the fifth consecutive year, according to an independent survey conducted by a leading market research consulting firm. Over 1,400 survey respondents, including department supervisors, lab managers, technologists and senior technologists chosen at random from hospitals of varying size from across the country, participated in the annual IMV ServiceTrak(TM) customer satisfaction survey.
The Consorta contract extension follows Sysmex America’s recent announcement that the company will begin supplying most of their reagent and control materials directly to many of their U.S. customers.
Consorta, based in suburban Chicago, is a leading healthcare resource management and group purchasing organization, whose shareholders are faith- based or non-profit health systems. For more information, visit http://www.consorta.com/.
About Sysmex
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systematization and solutions, including clinical diagnostics, automation and information systems that elevate clinical laboratory medicine to first-line patient care. Sysmex America, Inc. focuses on extending the boundaries of in vitro diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. Additional information about Sysmex America, Inc. can be found at http://www.sysmex.com/usa.
Sysmex America, Inc.
CONTACT: Tammy Kutz, Manager, Media & Events, Sysmex America,+1-847-996-4531, kutzt@sysmex.com
Web site: http://www.consorta.com/
Web site: http://www.sysmex.com/usa